$913 Million is the total value of Vivo Capital, LLC's 53 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 22.9% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
GTH | Genetron Holdings Ltdads | $104,570,306 | +1283.9% | 8,124,174 | 0.0% | 11.46% | +2094.6% | |
New | Soleno Therapeutics Inc | $94,523,274 | – | 3,203,093 | +100.0% | 10.36% | – | |
HRMY | Harmony Biosciences Holdings Inc | $85,406,714 | -6.9% | 2,606,247 | 0.0% | 9.36% | +47.8% | |
VRNA | Verona Pharma PLCads | $69,273,663 | -22.9% | 4,249,918 | 0.0% | 7.59% | +22.4% | |
AVDL | Buy | Avadel Pharmaceuticals PLCadr | $42,193,208 | -33.1% | 4,096,428 | +7.0% | 4.62% | +6.1% |
TARS | Tarsus Pharmaceuticals Inc | $40,199,294 | -1.7% | 2,262,200 | 0.0% | 4.40% | +56.1% | |
SVA | Sinovac Biotech Ltd. | $38,173,000 | -93.8% | 5,900,000 | 0.0% | 4.18% | -90.2% | |
GERN | Geron Corp | $35,032,224 | -34.0% | 16,524,634 | 0.0% | 3.84% | +4.8% | |
TERN | Terns Pharmaceuticals Inc | $33,489,700 | -42.5% | 6,657,992 | 0.0% | 3.67% | -8.8% | |
GRCL | Buy | Gracell Biotechnologies Incsponsored ads | $31,337,695 | +107.2% | 10,881,144 | +174.1% | 3.43% | +228.8% |
VRDN | Viridian Therapeutics Inc | $25,743,695 | -35.5% | 1,678,207 | 0.0% | 2.82% | +2.3% | |
OLMA | Buy | Olema Pharmaceuticals Inc | $23,140,244 | +91.3% | 1,873,704 | +39.9% | 2.54% | +203.6% |
COGT | Cogent Biosciences Inc | $21,888,175 | -17.7% | 2,244,941 | 0.0% | 2.40% | +30.7% | |
ALXO | ALX Oncology Holdings Inc | $20,256,230 | -36.1% | 4,220,048 | 0.0% | 2.22% | +1.4% | |
Buy | Arcellx Inc. | $18,067,912 | +31.7% | 503,565 | +16.1% | 1.98% | +109.0% | |
Ventyx Biosciences Inc | $14,658,665 | +5.9% | 422,075 | 0.0% | 1.61% | +68.0% | ||
New | Rayzebio Inc | $14,065,387 | – | 633,576 | +100.0% | 1.54% | – | |
Icosavax, Inc. | $13,210,402 | -22.0% | 1,704,568 | 0.0% | 1.45% | +23.9% | ||
Astria Therapeutics Inc | $12,541,745 | -10.4% | 1,681,199 | 0.0% | 1.37% | +42.1% | ||
Verastem Inc | $12,507,688 | +9.3% | 1,538,461 | 0.0% | 1.37% | +73.4% | ||
CMPS | New | Compass Pathway PLCsponsored ads | $11,899,200 | – | 1,608,000 | +100.0% | 1.30% | – |
ZLAB | Buy | Zai Lab Ltd ADRadr | $11,051,472 | -10.5% | 454,606 | +2.0% | 1.21% | +42.0% |
ALPN | Alpine Immune Sciences Inc | $10,475,754 | +11.4% | 914,913 | 0.0% | 1.15% | +76.9% | |
CRNX | New | Crinetics Pharmaceuticals Inc | $10,409,000 | – | 350,000 | +100.0% | 1.14% | – |
DYN | Buy | Dyne Therapeutics Inc | $9,274,819 | +42.7% | 1,035,136 | +79.2% | 1.02% | +126.3% |
Buy | IO Biotech Inc | $8,704,549 | +47.7% | 6,173,439 | +104.7% | 0.95% | +134.4% | |
New | Apogee Therapeutics Inc | $8,520,000 | – | 400,000 | +100.0% | 0.93% | – | |
KALV | KalVista Pharmaceuticals Inc. | $8,243,357 | +7.0% | 856,008 | 0.0% | 0.90% | +69.7% | |
DCTH | Buy | Delcath Systems, Inc. | $7,513,524 | +9.3% | 1,855,191 | +57.4% | 0.82% | +73.6% |
SVRA | New | Savara Inc | $7,232,459 | – | 1,913,349 | +100.0% | 0.79% | – |
CMPX | Compass Therapeutics Inc | $7,005,365 | -38.1% | 3,556,023 | 0.0% | 0.77% | -1.8% | |
ALLK | Allakos Inc | $6,782,760 | -47.9% | 2,988,000 | 0.0% | 0.74% | -17.4% | |
Aadi Bioscience Inc | $6,456,277 | 0.0% | 509,572 | 0.0% | 0.71% | +58.5% | ||
ACRS | Aclaris Therapeutics, Inc. | $6,155,622 | -33.9% | 898,631 | 0.0% | 0.67% | +4.8% | |
TIL | Instil Bio Inc | $5,344,345 | -22.3% | 12,486,787 | 0.0% | 0.59% | +23.4% | |
ORIC | New | Oric Pharmaceuticals Inc | $4,706,561 | – | 777,944 | +100.0% | 0.52% | – |
BOLT | Bolt Therapeutics Inc | $4,026,143 | -18.7% | 3,871,291 | 0.0% | 0.44% | +28.9% | |
ARWR | Arrowhead Pharmaceuticals Inc | $3,692,234 | -24.6% | 137,411 | 0.0% | 0.40% | +19.8% | |
DBVT | DBV Technologies SAsponsored adr | $3,684,070 | -28.4% | 2,708,875 | 0.0% | 0.40% | +13.8% | |
Sera Prognostics Inc | $3,452,180 | -43.6% | 1,856,011 | 0.0% | 0.38% | -10.4% | ||
IOVA | Iovance Biotherapeutics Inc | $2,980,509 | -35.4% | 655,057 | 0.0% | 0.33% | +2.8% | |
New | Unicycive Therapeutics | $2,984,331 | – | 3,470,152 | +100.0% | 0.33% | – | |
ALGS | Aligos Therapeutics Inc | $2,649,631 | -23.1% | 3,547,030 | 0.0% | 0.29% | +21.8% | |
FULC | Sell | Fulcrum Therapeutics Inc | $2,308,800 | +27.2% | 520,000 | -5.5% | 0.25% | +102.4% |
CLNN | Sell | Clene Inc | $1,396,738 | -62.3% | 2,645,338 | -41.5% | 0.15% | -40.2% |
IMPL | Impel NeuroPharma Inc | $1,240,459 | -66.1% | 2,884,789 | 0.0% | 0.14% | -46.2% | |
ASLN | Sell | Aslan Pharmaceuticals Ltdads | $1,068,181 | -89.7% | 568,182 | -80.0% | 0.12% | -83.7% |
BCAB | Sell | BioAtla Inc | $908,108 | -52.5% | 534,181 | -16.2% | 0.10% | -25.0% |
CDXS | Codexis, Inc | $733,592 | -32.5% | 388,144 | 0.0% | 0.08% | +6.7% | |
RZLT | Sell | Rezolute Inc | $639,459 | -34.0% | 484,439 | -1.0% | 0.07% | +4.5% |
AMRS | Amyris, Inc | $465,050 | -94.2% | 7,750,828 | 0.0% | 0.05% | -90.7% | |
FIXX | Homology Medicines, Inc. | $432,980 | +32.2% | 370,068 | 0.0% | 0.05% | +104.3% | |
DTIL | Precision Biosciences Inc | $47,869 | -35.1% | 140,255 | 0.0% | 0.01% | 0.0% | |
IMUX | Exit | Immunic Inc | $0 | – | -632,184 | -100.0% | -0.11% | – |
KDNY | Exit | Chinook Therapeutics Inc | $0 | – | -934,879 | -100.0% | -2.48% | – |
VECT | Exit | VectivBio Holding AG | $0 | – | -2,333,300 | -100.0% | -2.72% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-08
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ACLARIS THERAPEUTICS INC | 29 | Q3 2023 | 33.5% |
CODEXIS INC | 29 | Q3 2023 | 8.0% |
ASCENDIS PHARMA A/S | 25 | Q3 2022 | 24.0% |
KALVISTA PHARMACEUTICALS INC | 25 | Q3 2023 | 3.9% |
Verona Pharma PLC ADR | 24 | Q3 2023 | 7.6% |
AMYRIS INC | 23 | Q3 2023 | 8.8% |
EIGER BIOPHARMACEUTICALS INC | 23 | Q1 2022 | 8.7% |
Zai Lab Ltd ADR | 22 | Q3 2023 | 1.8% |
Arrowhead Pharmaceuticals Inc | 21 | Q3 2023 | 6.9% |
HOMOLOGY MEDICINES INC | 21 | Q3 2023 | 3.7% |
View Vivo Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
SINOVAC BIOTECH LTDSold out | August 27, 2018 | 0 | 0.0% |
View Vivo Capital, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-22 |
13F-HR | 2024-02-07 |
13F-HR | 2023-11-08 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
View Vivo Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.